Alembic Pharmaceuticals Limited Discontinued
FDA Approved Drugs

Alembic Pharmaceuticals Limited Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 28
  • Latest Approval Date Jun 14, 2021
  • Data Source FDA
  • First Approval Date May 05, 2010
All
533
View
Unclassified
10
View
Discontinued
28
View
OTC
4
View
RX
491
View
Company Overview

Company

Alembic Pharmaceuticals Limited Discontinued

Country

India

Website

Visit Website

Email

infoal@alembic.co.in

Social Profiles

LinkedIn
Company Snapshot

Alembic Pharmaceuticals Limited Discontinued

Alembic Road, Vadodara - 390 003, Gujarat

India

www.alembic-india.com/ infoal@alembic.co.in View on Map
FDA Approved Drug Records ( 28 records )
2020
23 Jan
Discontinued Application: 211461

Drug Name

BOSENTAN

Product Number

1

Dosage Form

-

Strength

62.5MG

Approval Date

2020-01-23

211461 / 1

Active Ingredient

BOSENTAN

Application Number

211461

Product Number

1

Dosage Form

-

Strength

62.5MG

Approval Date

2020-01-23

Regulatory Status

Discontinued

2020
23 Jan
Discontinued Application: 211461

Drug Name

BOSENTAN

Product Number

2

Dosage Form

-

Strength

125MG

Approval Date

2020-01-23

211461 / 2

Active Ingredient

BOSENTAN

Application Number

211461

Product Number

2

Dosage Form

-

Strength

125MG

Approval Date

2020-01-23

Regulatory Status

Discontinued

2020
14 May
Discontinued Application: 210536

Drug Name

DOXYCYCLINE HYCLATE

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2020-05-14

210536 / 1

Active Ingredient

DOXYCYCLINE HYCLATE

Application Number

210536

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2020-05-14

Regulatory Status

Discontinued

2020
17 Jan
Discontinued Application: 213252

Drug Name

FENOFIBRATE

Product Number

1

Dosage Form

-

Strength

54MG

Approval Date

2020-01-17

213252 / 1

Active Ingredient

FENOFIBRATE

Application Number

213252

Product Number

1

Dosage Form

-

Strength

54MG

Approval Date

2020-01-17

Regulatory Status

Discontinued

2020
17 Jan
Discontinued Application: 213252

Drug Name

FENOFIBRATE

Product Number

2

Dosage Form

-

Strength

160MG

Approval Date

2020-01-17

213252 / 2

Active Ingredient

FENOFIBRATE

Application Number

213252

Product Number

2

Dosage Form

-

Strength

160MG

Approval Date

2020-01-17

Regulatory Status

Discontinued

2010
30 Nov
Discontinued Application: 200645

Drug Name

HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2010-11-30

200645 / 1

Active Ingredient

HYDROCHLOROTHIAZIDE

Application Number

200645

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2010-11-30

Regulatory Status

Discontinued

2015
10 Jun
Discontinued Application: 204445

Drug Name

LITHIUM CARBONATE

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2015-06-10

204445 / 1

Active Ingredient

LITHIUM CARBONATE

Application Number

204445

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2015-06-10

Regulatory Status

Discontinued

2010
05 May
Discontinued Application: 90222

Drug Name

METRONIDAZOLE

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

2010-05-05

90222 / 1

Active Ingredient

METRONIDAZOLE

Application Number

90222

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

2010-05-05

Regulatory Status

Discontinued

2010
08 Oct
Discontinued Application: 78894

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.125MG

Approval Date

2010-10-08

78894 / 1

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

78894

Product Number

1

Dosage Form

-

Strength

0.125MG

Approval Date

2010-10-08

Regulatory Status

Discontinued

2010
08 Oct
Discontinued Application: 78894

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

0.25MG

Approval Date

2010-10-08

78894 / 2

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

78894

Product Number

2

Dosage Form

-

Strength

0.25MG

Approval Date

2010-10-08

Regulatory Status

Discontinued

2010
08 Oct
Discontinued Application: 78894

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

0.5MG

Approval Date

2010-10-08

78894 / 3

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

78894

Product Number

3

Dosage Form

-

Strength

0.5MG

Approval Date

2010-10-08

Regulatory Status

Discontinued

2010
08 Oct
Discontinued Application: 78894

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

1MG

Approval Date

2010-10-08

78894 / 4

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

78894

Product Number

4

Dosage Form

-

Strength

1MG

Approval Date

2010-10-08

Regulatory Status

Discontinued

2010
08 Oct
Discontinued Application: 78894

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

1.5MG

Approval Date

2010-10-08

78894 / 5

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

78894

Product Number

5

Dosage Form

-

Strength

1.5MG

Approval Date

2010-10-08

Regulatory Status

Discontinued

2014
28 Oct
Discontinued Application: 203390

Drug Name

QUETIAPINE FUMARATE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2014-10-28

203390 / 1

Active Ingredient

QUETIAPINE FUMARATE

Application Number

203390

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2014-10-28

Regulatory Status

Discontinued

2014
28 Oct
Discontinued Application: 203390

Drug Name

QUETIAPINE FUMARATE

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2014-10-28

203390 / 2

Active Ingredient

QUETIAPINE FUMARATE

Application Number

203390

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2014-10-28

Regulatory Status

Discontinued

2014
28 Oct
Discontinued Application: 203390

Drug Name

QUETIAPINE FUMARATE

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2014-10-28

203390 / 3

Active Ingredient

QUETIAPINE FUMARATE

Application Number

203390

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2014-10-28

Regulatory Status

Discontinued

2014
28 Oct
Discontinued Application: 203390

Drug Name

QUETIAPINE FUMARATE

Product Number

4

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2014-10-28

203390 / 4

Active Ingredient

QUETIAPINE FUMARATE

Application Number

203390

Product Number

4

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2014-10-28

Regulatory Status

Discontinued

2014
28 Oct
Discontinued Application: 203390

Drug Name

QUETIAPINE FUMARATE

Product Number

5

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2014-10-28

203390 / 5

Active Ingredient

QUETIAPINE FUMARATE

Application Number

203390

Product Number

5

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2014-10-28

Regulatory Status

Discontinued

2014
28 Oct
Discontinued Application: 203390

Drug Name

QUETIAPINE FUMARATE

Product Number

6

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2014-10-28

203390 / 6

Active Ingredient

QUETIAPINE FUMARATE

Application Number

203390

Product Number

6

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2014-10-28

Regulatory Status

Discontinued

2019
22 Nov
Discontinued Application: 211731

Drug Name

SILODOSIN

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

2019-11-22

211731 / 1

Active Ingredient

SILODOSIN

Application Number

211731

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

2019-11-22

Regulatory Status

Discontinued

2019
22 Nov
Discontinued Application: 211731

Drug Name

SILODOSIN

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

2019-11-22

211731 / 2

Active Ingredient

SILODOSIN

Application Number

211731

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

2019-11-22

Regulatory Status

Discontinued

2016
17 Nov
Discontinued Application: 205234

Drug Name

TELMISARTAN AND AMLODIPINE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;40MG

Approval Date

2016-11-17

205234 / 1

Active Ingredient

AMLODIPINE BESYLATE; TELMISARTAN

Application Number

205234

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;40MG

Approval Date

2016-11-17

Regulatory Status

Discontinued

2016
17 Nov
Discontinued Application: 205234

Drug Name

TELMISARTAN AND AMLODIPINE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE;40MG

Approval Date

2016-11-17

205234 / 2

Active Ingredient

AMLODIPINE BESYLATE; TELMISARTAN

Application Number

205234

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE;40MG

Approval Date

2016-11-17

Regulatory Status

Discontinued

2016
17 Nov
Discontinued Application: 205234

Drug Name

TELMISARTAN AND AMLODIPINE

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE;80MG

Approval Date

2016-11-17

205234 / 3

Active Ingredient

AMLODIPINE BESYLATE; TELMISARTAN

Application Number

205234

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE;80MG

Approval Date

2016-11-17

Regulatory Status

Discontinued

2016
17 Nov
Discontinued Application: 205234

Drug Name

TELMISARTAN AND AMLODIPINE

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;80MG

Approval Date

2016-11-17

205234 / 4

Active Ingredient

AMLODIPINE BESYLATE; TELMISARTAN

Application Number

205234

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;80MG

Approval Date

2016-11-17

Regulatory Status

Discontinued

2021
14 Jun
Discontinued Application: 212882

Drug Name

TESTOSTERONE

Product Number

1

Dosage Form

-

Strength

30MG/1.5ML ACTUATION

Approval Date

2021-06-14

212882 / 1

Active Ingredient

TESTOSTERONE

Application Number

212882

Product Number

1

Dosage Form

-

Strength

30MG/1.5ML ACTUATION

Approval Date

2021-06-14

Regulatory Status

Discontinued

2021
03 Mar
Discontinued Application: 213922

Drug Name

TESTOSTERONE

Product Number

1

Dosage Form

-

Strength

1.62% (20.25MG/1.25GM ACTUATION)

Approval Date

2021-03-03

213922 / 1

Active Ingredient

TESTOSTERONE

Application Number

213922

Product Number

1

Dosage Form

-

Strength

1.62% (20.25MG/1.25GM ACTUATION)

Approval Date

2021-03-03

Regulatory Status

Discontinued

2019
20 Dec
Discontinued Application: 210458

Drug Name

TRAVOPROST

Product Number

1

Dosage Form

-

Strength

0.004%

Approval Date

2019-12-20

210458 / 1

Active Ingredient

TRAVOPROST

Application Number

210458

Product Number

1

Dosage Form

-

Strength

0.004%

Approval Date

2019-12-20

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    31 View
  • EDQM CEP
    66 View
  • KDMF
    0 View
  • Japan DMF
    15 View
  • Eudra GMP
    0 View
  • NDC Database
    20 View
  • FDA Approved Drugs Database
    533 View
Drug Status Breakdown
28 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BOSENTAN

Application Number

211461

Product Number

1

Active Ingredient

BOSENTAN

Dosage Form

-

Strength

62.5MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit